Daniel A. Vallera

9.8k citations
202 papers · 8.1k · h-index 52

Impact in

  • Immunology top 0.2%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Toxin Mechanisms and Immunotoxins
    • Immunotherapy and Immune Responses
  • Hematology top 0.2%
    • Hematopoietic Stem Cell Transplantation

Papers in

  • Immunology 153
    • Toxin Mechanisms and Immunotoxins 76
    • Immune Cell Function and Interaction 45
    • Immunotherapy and Immune Responses 37
    • T-cell and B-cell Immunology 28
  • Oncology 59
    • CAR-T cell therapy research 42
Co-authors
Bruce R. Blazar (47 shared papers)Angela Panoskaltsis‐Mortari (36 shared papers)Jeffrey S. Miller (33 shared papers)Patricia A. Taylor (17 shared papers)Martin Felices (28 shared papers)John H. Kersey (12 shared papers)CHRISTINE C. B. SODERLING (12 shared papers)D.A. Todhunter (19 shared papers)
Journals
The Journal of Immunology (24 papers)Blood (19 papers)Transplantation (18 papers)Journal of Neuro-Oncology (9 papers)Clinical Cancer Research (8 papers)
Partner nations
United StatesUnited KingdomGermany

In The Last Decade

Daniel A. Vallera

199 papers receiving 7.9k citations

Peers

Daniel A. Vallera
Comparison fields: 5 of 120
  • Immunology 5.1k
  • Hematology 2.2k
  • Oncology 2.9k
  • Biotechnology 916
  • Radiology, Nuclear Medicine and Imaging 1.1k
Replace Josée Golay with:
Josée Golay Italy
Martin A. Cheever United States
Catia Traversari Italy
Thomas Valerius Germany
Tuna Mutis Netherlands
Clive R. Wood United States
Alan J. Korman United States
Irwin D. Bernstein United States
Ivor Royston United States
Richard P. Junghans United States
Daniel A. Vallera relative to Josée Golay Italy Josée Golay's profile →
Citations per field
00.5×2×3×3.6×
Josée Golay · 1×
Citations per year

Countries citing papers authored by Daniel A. Vallera

Since Specialization
Citations

This map shows the geographic impact of Daniel A. Vallera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Vallera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Vallera more than expected).

Fields of papers citing papers by Daniel A. Vallera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Vallera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Vallera. The network helps show where Daniel A. Vallera may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel A. Vallera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel A. Vallera Line = papers co-authored together Daniel A. Vallera links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 202 papers — load more, or switch the sort, to bring in the rest.

#Work
1
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
Clinical Cancer Research ·Daniel A. Vallera, Martin Felices, Ron McElmurry, Valarie McCullar, Xianzheng Zhou, Joerg Uwe Schmohl, Bin Zhang, Alexander J. Lenvik, Angela Panoskaltsis‐Mortari, Michael R. Verneris, Jakub Tolar, Sarah Cooley, Daniel J. Weisdorf, Bruce R. Blazar, Jeffrey S. Miller
2016304
2
Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia
New England Journal of Medicine ·John H. Kersey, Daniel Weisdorf, Mark E. Nesbit, Tucker W. LeBien, William G. Woods, Philip B. McGlave, Tae Il Kim, Daniel A. Vallera, Anne I. Goldman, Bruce Bostrom, David D. Hurd, Norma K.C. Ramsay
1987266
3
Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia
Blood ·Qing Zhou, Meghan E. Munger, Steven L. Highfill, Jakub Tolar, Brenda J. Weigel, Megan Riddle, Arlene H. Sharpe, Daniel A. Vallera, Miyuki Azuma, Bruce L. Levine, Carl H. June, William J. Murphy, David H. Munn, Bruce R. Blazar
2010233
4
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
Blood ·Michelle Gleason, Julie A. Ross, Erica D. Warlick, Troy C. Lund, Michael R. Verneris, Andres Wiernik, Stephen R. Spellman, Michael Haagenson, Alexander J. Lenvik, Mark R. Litzow, Pearlie K. Epling‐Burnette, Bruce R. Blazar, Louis M. Weiner, Daniel J. Weisdorf, Daniel A. Vallera, Jeffrey S. Miller
2014213
5
3D Bioprinted In Vitro Metastatic Models via Reconstruction of Tumor Microenvironments
Advanced Materials ·Fanben Meng, Carolyn Meyer, Daeha Joung, Daniel A. Vallera, Michael C. McAlpine, Angela Panoskaltsis‐Mortari
2019206
6
Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
Molecular Cancer Therapeutics ·Michelle Gleason, Michael R. Verneris, D.A. Todhunter, Bin Zhang, Valarie McCullar, Sophia X. Zhou, Angela Panoskaltsis‐Mortari, Louis M. Weiner, Daniel A. Vallera, Jeffrey S. Miller
2012193
7
Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
Journal of Clinical Investigation ·W J Murphy, (unknown), D D Taub, Robert H. Wiltrout, Patricia A. Taylor, Daniel A. Vallera, Manfred Köpf, Howard A. Young, Dan L. Longo, Bruce R. Blazar
1998181
8
Targeting Natural Killer Cells to Acute Myeloid LeukemiaIn Vitrowith a CD16 × 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
Clinical Cancer Research ·Andres Wiernik, Bree Foley, Bin Zhang, Michael R. Verneris, Erica D. Warlick, Michelle Gleason, Julie A. Ross, Xianghua Luo, Daniel J. Weisdorf, Bruce Walcheck, Daniel A. Vallera, Jeffrey S. Miller
2013178
9
Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation
The Journal of Immunology ·Bruce R. Blazar, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, J Buhlman, Jinhua Xu, R. A. Flavell, Robert Korngold, Randolph J. Noelle, Daniel A. Vallera
1997151
10
Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells
Methods in molecular biology ·Martin Felices, Todd Lenvik, Zachary Davis, Jeffrey S. Miller, Daniel A. Vallera
2016135
11
Anti-T-Cell Reagents for Human Bone Marrow Transplantation: Ricin Linked to Three Monoclonal Antibodies
Science ·Daniel A. Vallera, Robert C. Ash, Esmail D. Zanjani, John H. Kersey, Tucker W. LeBien, Peter C. L. Beverley, David M. Neville, Richard J. Youle
1983129
12
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
Blood ·Qing Zhou, Christoph Bucher, Meghan E. Munger, Steven L. Highfill, Jakub Tolar, David H. Munn, Bruce L. Levine, Megan Riddle, Carl H. June, Daniel A. Vallera, Brenda J. Weigel, Bruce R. Blazar
2009121
13
Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia.
The Journal of Experimental Medicine ·Fatih M. Uckun, K Gajl-Peczalska, John H. Kersey, L. L. Houston, Daniel A. Vallera
1986115
14
Keratinocyte Growth Factor Administered Before Conditioning Ameliorates Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation in Mice
Blood ·Angela Panoskaltsis‐Mortari, David L. Lacey, Daniel A. Vallera, Bruce R. Blazar
1998110
15
Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
Seminars in Immunology ·Zachary Davis, Daniel A. Vallera, Jeffrey S. Miller, Martin Felices
2017109
16
BONE MARROW TRANSPLANTATION ACROSS MAJOR HISTOCOMPATIBILITY BARRIERS IN MICE EFFECT OF ELIMINATION OF T CELLS FROM DONOR GRAFTS BY TREATMENT WITH MONOCLONAL THY-1.2 PLUS COMPLEMENT OR ANTIBODY ALONE
Transplantation ·Daniel A. Vallera, CHRISTINE C. B. SODERLING, G. Joanne Carlson, John H. Kersey
1981104
17
The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide.
Journal of Clinical Investigation ·Angela Panoskaltsis‐Mortari, Patricia A. Taylor, Thomas M Yaeger, O. Douglas Wangensteen, Peter B. Bitterman, David H. Ingbar, Daniel A. Vallera, Bruce R. Blazar
1997102
18
Opposing Roles of CD28:B7 and CTLA-4:B7 Pathways in Regulating In Vivo Alloresponses in Murine Recipients of MHC Disparate T Cells
The Journal of Immunology ·Bruce R. Blazar, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, Arlene H. Sharpe, Daniel A. Vallera
1999100
19
Keratinocyte Growth Factor Administered Before Conditioning Ameliorates Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation in Mice
Blood ·Angela Panoskaltsis‐Mortari, David L. Lacey, Daniel A. Vallera, Bruce R. Blazar
199895
20
161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS
Blood Advances ·Dhifaf Sarhan, Ludwig Brandt, Martin Felices, Karolin Guldevall, Todd Lenvik, Peter Hinderlie, Julie Curtsinger, Erica D. Warlick, Stephen R. Spellman, Bruce R. Blazar, Daniel J. Weisdorf, Sarah Cooley, Daniel A. Vallera, Björn Önfelt, Jeffrey S. Miller
201895

About Daniel A. Vallera

Daniel A. Vallera is a scholar working on Immunology, Oncology, Hematology, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 202 papers that have together received 8.1k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (76 papers), Immune Cell Function and Interaction (45 papers), CAR-T cell therapy research (42 papers), Monoclonal and Polyclonal Antibodies Research (40 papers), Hematopoietic Stem Cell Transplantation (39 papers), Immunotherapy and Immune Responses (37 papers), Transgenic Plants and Applications (29 papers) and T-cell and B-cell Immunology (28 papers). The work is most often cited by research in Immunology (5.1k citations), Hematology (2.2k citations), Oncology (2.9k citations), Biotechnology (916 citations) and Radiology, Nuclear Medicine and Imaging (1.1k citations). Daniel A. Vallera has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Bruce R. Blazar, Angela Panoskaltsis‐Mortari, Jeffrey S. Miller, Patricia A. Taylor, Martin Felices, John H. Kersey, CHRISTINE C. B. SODERLING, D.A. Todhunter, Fatih M. Uckun and Michael R. Verneris. Their work appears in journals such as The Journal of Immunology, Blood, Transplantation, Journal of Neuro-Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josée GolayBreakdown of academic impact, for papers by Martin A. CheeverBreakdown of academic impact, for papers by Catia TraversariBreakdown of academic impact, for papers by Thomas ValeriusBreakdown of academic impact, for papers by Tuna MutisBreakdown of academic impact, for papers by Clive R. WoodBreakdown of academic impact, for papers by Alan J. KormanBreakdown of academic impact, for papers by Irwin D. BernsteinBreakdown of academic impact, for papers by Ivor RoystonBreakdown of academic impact, for papers by Richard P. Junghans